SecBot SecBot
Insider Cluster (2 insiders) ·Filed May 22, 2026

ABEO

ABEONA THERAPEUTICS INC.
NEUTRAL
Impact 2/10
Horizondays Processed5mo ago
Insider cluster: 2 insiders, $180K total
Actionable Insight • Neutral

The insider sales are immaterial in size and involve only directors, not C-suite. No bearish signal. Monitor for any C-suite selling or larger volume (>0.5% of market cap) in coming weeks, but this cluster alone does not warrant action.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$5.49
T+0 close · May 22, 2026 · via day close
Latest settled
+11.66%
T+60 · $6.13
Vs SPY
+8.93%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 26 $5.49entry
  2. T+1 · 6mo ago +3.64%α +3.63% · $5.69
  3. T+5 · 6mo ago +3.64%α +2.43% · $5.69
  4. T+20 · 5mo ago +3.92%α +5.86% · $5.71
  5. T+60 · 3mo ago +11.66%α +8.93% · $6.13

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Two directors at Abeona Therapeutics sold a total of $180K in open-market transactions within a week of the company's Q1 2026 earnings report. The sales are small relative to the $315M market cap (0.06%) and are not clustered among C-suite executives, making them routine portfolio adjustments rather than informed selling.

Key Financial Metrics

Direction
selling
Total Value
$180.0K
Insiders
2

Key Facts

  • Director Mark Alvino sold 6,500 shares at $5.46 for $35K on May 22, 2026
  • Director Eric Crombez sold 26,100 shares at $5.53 for $145K on May 15, 2026
  • Total insider sales of $180K represent 0.06% of $315M market cap
  • Both sellers are directors, not C-suite executives
  • Sales occurred 2-9 days after Q1 2026 earnings release (net product revenue $8.7M, net loss -$17.1M)

Financial Impact

Insider sales of $180K, or 0.06% of market cap, trivial

insider ownership

Risk Factors

  • No material risk from this cluster, sales are routine and small

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
92% bullish (12 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-ABEO-1779485088592

Track record

29 reports on ABEO

Performance horizon

4 of 7 bullish or bearish reports moved the stock their way by T+1. Best: +15.24% at T+20 after the Sep 29, 2026 report. 4 of 7 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G Neutral 4/10 Entry price pending
  2. Nov 13, 20263d ago SC 13G/A Neutral 3/10 Entry $2.30 Now $2.60 +13.04% settles Nov 17
  3. Nov 12, 20264d ago SC 13G/A Neutral 3/10 Entry $2.29 to $2.42 Now $2.60 +13.54% ▲ +5.68% +6.04% vs SPY
  4. Nov 9, 20267d ago Press Release Neutral 5/10 Entry $2.54 to $2.46 Now $2.60 +2.36% ▼ −3.35% −2.98% vs SPY
  5. Nov 9, 20267d ago 8-K Bearish 6/10 Entry $2.54 to $2.46 Now $2.60 −2.36% ▲ +3.35% +2.98% vs SPY
  6. Nov 9, 20267d ago Press Release Mixed 6/10 Entry $2.54 to $2.46 Now $2.60 +2.36% ▼ −3.35% −2.98% vs SPY
  7. Nov 6, 202610d ago Institutional Cluster Neutral 3/10 Entry $4.17 to $2.54 Now $2.60 −37.65% ▼ −39.09% −41.46% vs SPY
  8. Oct 23, 202624d ago SC 13D Bullish 6/10 Entry $4.40 to $4.31 Now $2.60 −40.91% ▼ −2.05% −2.76% vs SPY
  9. Sep 29, 20266w ago Insider Cluster Bearish 4/10 Entry $5.25 to $5.01 Now $2.60 +50.48% ▲ +4.57% +4.75% vs SPY
  10. Sep 18, 20268w ago Press Release Bullish 6/10 Entry $5.57 to $5.67 Now $2.60 −53.32% ▲ +1.80% +0.24% vs SPY
Showing 10 of 29

US Market Status

Market Closed · Opens Wed (10h 49m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 22, 2026